Chemical biology and proteomic strategies have rapidly emerged as cost effective yet powerful preclinical approaches for the discovery and identification of novel drugs and targets. Advances in the development and combination of novel chemical tools, bioorthogonal techniques, disease-relevant phenotypic systems, chemoinformatics, and chemical proteomics now provide robust and high-throughput workflows for interrogating drug-target-phenotype relationships. These efforts are poised to significantly enrich preclinical discovery programs and are illuminating a new paradigm for the development of novel drugs modulating novel targets.
Cambridge Healthtech Institute’s Chemical Biology in Drug Discovery will once again gather an interdisciplinary collection of leaders to discuss these emerging tools and strategies to de-risk novel discovery initiatives.
The 2016 Conference is jointly organized by the International Union of Biochemistry and Molecular Biology (IUBMB), the Canadian Society for Molecular Biosciences (CSMB) and the Pan-American Association for Biochemistry and Molecular Biology (PABMB). The theme of the 2016 Conference ‘Signalling Pathways in Development, Disease and Aging’ will underpin the need for collaboration and cooperation of individuals from a wide range of professional backgrounds. The program will include Plenary speakers from Nobel Prize and Gairdner Award winners, workshops, industry and poster sessions. Call for abstracts is now open until March 4, 2016 with early bird registration open in February, 2016.
The 2016 BSPR conference will aim at bringing together people who are using and developing proteomics approaches in the fields of health and disease. The conference will host speakers who have made significant contributions in the medical, biological, veterinary and microbiological fields. It will be a unique opportunity for the participants to update themselves on current research and state-of-the-art techniques and discuss their research in an informal and friendly atmosphere.
It is our great pleasure to invite you on behalf of the Polish Biochemical Society and Polish Cell Biology Society to the 2nd Congress of Polish Biochemistry, Cell biology, Biotechnology and Bioinformatics “Bio2016 – Expanding beyond the limits” to be held in Wroclaw in 2016. The Bio2016 Congress will take place from September 13 to 16, 2016, at the University of Wroclaw, Poland. With this joint congress, the organizers expect to bring together a wide range of researchers from all field of biosciences. The Congress joint events will cover the entire spectrum of molecular biosciences with symposia from single molecule level to system biology. In addition, there will be sessions on women in science, science & business and science & society. The registration and abstract submission will start since February, 2016.
Plenary speakers include Nobel laureate Ada Yonath (Weizmann Institute of Science, Rehovot), Alexander Wlodawer (Center for Cancer Research, Frederick), Krzysztof Palczewski (Case Western Reserve University, Cleveland) and Nicolaus Rajewsky (Max Delbrück Center for Molecular Medicine, Berlin).
Through the tremendous advances in the technology of mass spectrometry-based proteomics and its applications, the research has expanded to most areas of biology that deal with proteins. This conference will focus on the application of proteomics to cell biology and unraveling disease mechanisms by addressing conceptually novel ways to study long-standing questions in these fields.
As 2016 marks the 20th year since the word “proteomics” was coined, the progress this scientific community has collectively achieved is tremendous. Today, we witness the real and exciting prospects of a human proteome map that can be tapped into for precision medicine. By the twin track of deep proteome sequencing and target quantification, combining the mass spectrometry techniques of data dependent and independent acquisition, complementary top-down and bottom up analysis, along with a host of non-MS-based systems approaches, we stand now to revolutionize our perception of the proteomic landscape and with it the very basics of all molecular and cellular processes. For the past years, HUPO has been making a great evolution on advancing the science of proteome. To continue the object from the past congress, the HUPO 2016 in Taipei is focusing on “Precision Proteomics for Precision Biology and Medicine”. This unique platform is going to provide a great opportunity for proteomics scientists to stimulate and exchange the most up-to-date science knowledge.